359 related articles for article (PubMed ID: 19429588)
1. Mantle cell lymphoma in the orbital and adnexal region.
Rasmussen P; Sjö LD; Prause JU; Ralfkiaer E; Heegaard S
Br J Ophthalmol; 2009 Aug; 93(8):1047-51. PubMed ID: 19429588
[TBL] [Abstract][Full Text] [Related]
2. Mantle cell lymphoma in the ocular adnexal region.
Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
[TBL] [Abstract][Full Text] [Related]
3. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
4. Diffuse large B-cell lymphoma of the ocular adnexal region: a nation-based study.
Rasmussen PK; Ralfkiaer E; Prause JU; Sjö LD; Toft PB; Siersma VD; Heegaard S
Acta Ophthalmol; 2013 Mar; 91(2):163-9. PubMed ID: 22551232
[TBL] [Abstract][Full Text] [Related]
5. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
6. Clinical features associated with survival of patients with lymphoma of the ocular adnexa.
Jenkins C; Rose GE; Bunce C; Cree I; Norton A; Plowman PN; Moseley I; Wright JE
Eye (Lond); 2003 Oct; 17(7):809-20. PubMed ID: 14528242
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219
[TBL] [Abstract][Full Text] [Related]
8. Follicular lymphoma of the ocular adnexal region: a nation-based study.
Rasmussen PK; Ralfkiaer E; Prause JU; Sjö LD; Specht L; Rossing HH; Siersma VD; Heegaard S
Acta Ophthalmol; 2015 Mar; 93(2):184-91. PubMed ID: 25125069
[TBL] [Abstract][Full Text] [Related]
9. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa.
Lee JL; Kim MK; Lee KH; Hyun MS; Chung HS; Kim DS; Shin SO; Cho HS; Bae SH; Ryoo HM
Ann Hematol; 2005 Jan; 84(1):13-8. PubMed ID: 15309523
[TBL] [Abstract][Full Text] [Related]
10. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases.
Demirci H; Shields CL; Karatza EC; Shields JA
Ophthalmology; 2008 Sep; 115(9):1626-31, 1631.e1-3. PubMed ID: 18440641
[TBL] [Abstract][Full Text] [Related]
11. Ocular adnexal follicular lymphoma: a multicenter international study.
Rasmussen PK; Coupland SE; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; McKelvie P; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Heegaard S
JAMA Ophthalmol; 2014 Jul; 132(7):851-8. PubMed ID: 24763920
[TBL] [Abstract][Full Text] [Related]
12. Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.
Inamdar KV; Romaguera JE; Drakos E; Knoblock RJ; Garcia M; Leventaki V; Medeiros LJ; Rassidakis GZ
Cancer; 2009 Oct; 115(20):4727-36. PubMed ID: 19708031
[TBL] [Abstract][Full Text] [Related]
13. Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT).
Rosenbluth BD; Yahalom J
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1185-91. PubMed ID: 16682133
[TBL] [Abstract][Full Text] [Related]
14. Ophthalmic lymphoma: epidemiology and pathogenesis.
Sjö LD
Acta Ophthalmol; 2009 Feb; 87 Thesis 1():1-20. PubMed ID: 19178392
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of ocular adnexal non-Hodgkin lymphoma].
Yi WS; Xu XL; Xiang Q; Jiang HB
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):826-30. PubMed ID: 18812662
[TBL] [Abstract][Full Text] [Related]
16. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes.
Hoffman PM; McKelvie P; Hall AJ; Stawell RJ; Santamaria JD
Eye (Lond); 2003 May; 17(4):513-21. PubMed ID: 12802353
[TBL] [Abstract][Full Text] [Related]
17. Mantle cell lymphoma of the maxillary sinus invading the orbit.
Nagel-Esposito AD; Kawasaki B; Jew R; Fujimoto L
Optometry; 2011 Jan; 82(1):22-31. PubMed ID: 21146791
[TBL] [Abstract][Full Text] [Related]
18. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
[TBL] [Abstract][Full Text] [Related]
20. BCL10 expression in ocular adnexal lymphomas.
Vejabhuti C; Harris GJ; Erickson BA; Nishino H; Chevez-Barrios P; Chang CC
Am J Ophthalmol; 2005 Nov; 140(5):836-843. PubMed ID: 16310461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
